VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CDLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CDLXCardlytics, Inc.
$4.87$28M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCDLXFinancials

Cardlytics, Inc. (CDLX) Financials

11Y historyFree accessUpdated daily

Top-line performance has deteriorated sharply, with revenue contracting by 44.6% in 2026Q1 while operating margins remain deeply negative at -24.1%.

CDLX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Sales/Revenue205.69M233.27M278.3M309.2M298.54M267.12M186.89M210.43M150.68M130.37M112.82M77.63M
Revenue Growth %-24.54%-16.18%-10%3.57%11.76%42.93%-11.19%39.65%15.59%15.55%45.32%-
Cost of Goods Sold109.1M128.19M157.4M178.83M185.91M163.78M123.62M130.97M96M80.26M72.41M52.49M
COGS % of Revenue-54.95%56.56%57.83%62.27%61.31%66.14%62.24%63.71%61.56%64.18%67.62%
Gross Profit96.59M105.08M120.89M130.38M112.63M103.34M63.27M79.46M54.68M50.11M40.41M25.14M
Gross Margin %46.96%45.05%43.44%42.17%37.73%38.69%33.86%37.76%36.29%38.44%35.82%32.38%
Gross Profit Growth %--13.08%-7.27%15.76%8.99%63.32%-20.37%45.31%9.13%24%60.74%-
Operating Expenses190.61M152.22M316.39M266.05M570.41M225.94M117.2M96.78M95.6M67.2M70.74M64.78M
OpEx % of Revenue-65.25%113.69%86.04%191.07%84.58%62.71%45.99%63.44%51.55%62.7%83.44%
Selling, General & Admin73.82M86.75M109.13M116.24M156.19M132.22M91.84M80.55M76.11M52.03M52.62M50.98M
SG&A % of Revenue-37.19%39.21%37.59%52.32%49.5%49.14%38.28%50.51%39.91%46.64%65.67%
Research & Development34.49M39.77M49.61M51.35M54.44M38.1M17.53M11.7M16.21M12.15M13.9M11.6M
R&D % of Revenue-17.05%17.83%16.61%18.23%14.27%9.38%5.56%10.76%9.32%12.32%14.95%
Other Operating Expenses4M25.71M157.66M98.46M359.78M55.62M7.83M4.54M-2.1M6.28M-13.26M-432K
Operating Income-94.02M-47.14M-195.5M-135.67M-457.78M-122.6M-53.92M-17.32M-40.92M-17.1M-56.23M-39.64M
Operating Margin %-45.71%-20.21%-70.25%-43.88%-153.34%-45.9%-28.85%-8.23%-27.15%-13.12%-49.84%-51.06%
Operating Income Growth %-75.89%-44.1%70.36%-273.39%-127.36%-211.24%57.66%-139.29%69.59%-41.86%-
EBITDA-69.3M-19.73M-167.62M-106.16M-414.04M-86.94M-42.33M-12.79M-37.63M-14.07M-52.01M-37.45M
EBITDA Margin %-33.69%-8.46%-60.23%-34.33%-138.69%-32.55%-22.65%-6.08%-24.98%-10.79%-46.1%-48.23%
EBITDA Growth %56.34%88.23%-57.9%74.36%-376.21%-105.39%-230.97%66.02%-167.47%72.95%-38.91%-
D&A (Non-Cash Add-back)24.71M27.41M27.88M29.52M43.74M35.65M11.59M4.54M3.28M3.03M4.22M2.19M
EBIT-92.95M-92.86M-180.4M-128.52M-464.15M-123.87M-52.37M-16.6M-49.78M-11.31M-30.33M-39.64M
Net Interest Income-8.62M-7.92M-5.55M-2.34M-2.56M-12.56M-3.05M-548K-3.26M-8.24M-6.17M-1.48M
Interest Income2.43M2.71M3.35M3.85M1.44M297K440K829K0000
Interest Expense11.05M10.63M8.9M6.18M3.99M12.86M3.49M1.38M3.26M8.24M6.17M1.48M
Other Income/Expense-9.99M-56.35M6.2M968K-8.93M-13.83M-1.5M181K-12.13M-2.54M-19.46M-1M
Pretax Income-104M-103.49M-189.3M-134.7M-466.71M-136.43M-55.42M-17.14M-53.04M-19.64M-75.7M-40.64M
Pretax Margin %-50.56%-44.36%-68.02%-43.56%-156.33%-51.07%-29.65%-8.15%-35.2%-15.07%-67.09%-52.35%
Income Tax0000-1.45M-7.86M00000-16K
Effective Tax Rate %0%0%0%0%0.31%5.76%0%0%0%0%0%0.04%
Net Income-94.69M-103.49M-189.3M-134.7M-465.26M-128.56M-55.42M-17.14M-53.04M-19.64M-75.7M-40.63M
Net Margin %-46.03%-44.36%-68.02%-43.56%-155.85%-48.13%-29.65%-8.15%-35.2%-15.07%-67.09%-52.33%
Net Income Growth %46.9%45.33%-40.54%71.05%-261.89%-131.97%-223.27%67.68%-170.06%74.05%-86.33%-
Net Income (Continuing)-104M-103.49M-189.3M-134.7M-465.26M-128.56M-55.42M-17.14M-53.04M-19.64M-75.7M-40.63M
Discontinued Operations1000K00000000000
Minority Interest000000000000
EPS (Diluted)-17.25-19.50-39.10-36.90-139.20-39.90-21.50-7.50-27.80-10.10-54.00-190.00
EPS Growth %49.95%50.13%-5.96%73.49%-248.87%-85.58%-186.67%73.02%-175.25%81.3%71.58%-
EPS (Basic)--19.50-39.10-36.90-139.20-39.90-21.50-7.50-27.80-10.10-54.00-190.00
Diluted Shares Outstanding5.49M5.31M4.84M3.65M3.34M3.22M2.72M2.37M1.91M1.95M1.4M213.82K
Basic Shares Outstanding5.49M5.31M4.84M3.65M3.34M3.22M2.72M2.37M1.91M1.95M1.4M213.82K
Dividend Payout Ratio------------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Revenue contraction and cash burn

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Top Line Contraction Accelerates Sharply

As reported in recent financial statements, Cardlytics experienced a severe revenue decline of 44.6% in 2026Q1, marking a significant deterioration from the 24.2% contraction observed in the prior quarter and highlighting a deepening struggle to maintain volume within its core bank-partner advertising network.

The consistent downward trend in revenue suggests that the company is failing to capture sufficient advertiser demand to offset the inherent volatility of its transactional model. This trajectory warrants concern, as it implies that the platform's value proposition to merchants may be losing relevance in a competitive digital advertising landscape.

Structural Margin Constraints Limit Profitability

Based on the company's reported figures, gross margins have remained range-bound near 45%, reflecting the rigid cost of revenue associated with FI Share payments that effectively cap the firm's ability to retain a larger portion of its advertising billings during periods of top-line weakness.

The inability to expand gross margins despite fluctuations in revenue suggests a lack of pricing power and a high dependency on bank partners. Investors should monitor whether the company can renegotiate these revenue-share floors, as the current structure leaves little room for operational profitability at lower scale.

Operating Leverage Remains Elusive Negative

According to recent SEC filings, the company's operating margin reached -24.1% in 2026Q1, demonstrating that fixed costs in R&D and SG&A are not scaling efficiently with revenue, thereby exacerbating the impact of top-line declines on the firm's overall bottom-line performance and cash position.

The persistent negative operating margins indicate that the business model has yet to achieve the necessary scale to cover its fixed overhead. This suggests that without a significant revenue inflection, the company may continue to face substantial pressure on its operating income and overall financial stability.

Stock-Based Compensation Obscures True Losses

Analysis of the income statement reveals that stock-based compensation remains a persistent expense, with $4.8M recorded in 2026Q1, which continues to mask the underlying cash burn and complicates the assessment of the company's true economic profitability relative to its reported net loss of $4.5M.

The reliance on equity-based incentives while the company reports consistent net losses suggests a misalignment between compensation and shareholder value creation. This warrants further investigation into the sustainability of the current expense structure and the potential for continued dilution of existing shareholders.

Platform Stickiness Faces Insourcing Risk

While the company maintains deep technical integrations with major banks, the recent emergence of internal media networks at key partners suggests a potential shift toward insourcing, which could fundamentally undermine the company's role as the primary intermediary for card-linked advertising and threaten its long-term viability.

The bear case centers on the risk that bank partners may prioritize their own retail media ambitions over the company's platform. If these partners successfully transition to internal solutions, the company's core revenue stream may face permanent impairment, regardless of its historical data-sharing agreements.

CDLX — Frequently Asked Questions

Quick answers to the most common questions about buying CDLX stock.

What was Cardlytics, Inc.'s (CDLX) revenue in 2025?

For fiscal year 2025, Cardlytics, Inc. (CDLX) reported total revenue of $233.3M. This represents a 200.5% increase compared to $77.6M in 2015.

Is Cardlytics, Inc. (CDLX) profitable?

Cardlytics, Inc. (CDLX) reported a net loss of $103.5M for the fiscal year ending 2025.

What is Cardlytics, Inc.'s operating profit margin?

Cardlytics, Inc. (CDLX) reported an operating income of $-47.1M, resulting in an operating profit margin of -20.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Cardlytics, Inc.'s gross profit and gross margin?

Cardlytics, Inc. (CDLX) generated $105.1M in gross profit for the year, representing a gross profit margin of 45.0%. This demonstrates the company's core pricing power and production efficiency.